Shinva Medical Instrument Co (SHSE:600587) Cyclically Adjusted Revenue per Share: ¥19.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600587 Shinva Medical Instrument Co Ltd SHSE:600587
65 GF Score
Price ¥12.98
GF Value ¥15.64
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shinva Medical Instrument Co Cyclically Adjusted Revenue per Share?

Shinva Medical Instrument Co SHSE:600587 -0.15% 65 Cyclically Adjusted Revenue per Share is ¥19.28 as of Mar. 2026. GuruFocus rates SHSE:600587 with a GF Score™ of 65/100 and a GF Value™ of ¥15.64 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Shinva Medical Instrument Co's adjusted revenue per share for the three months ended in Mar. 2026 was ¥3.634. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥19.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shinva Medical Instrument Co's average Cyclically Adjusted Revenue Growth Rate was 0.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Shinva Medical Instrument Co was 30.30% per year. The lowest was 2.40% per year. And the median was 17.75% per year.

As of today (2026-07-31), Shinva Medical Instrument Co's current stock price is ¥12.98. Shinva Medical Instrument Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ¥19.28. Shinva Medical Instrument Co's Cyclically Adjusted PS Ratio of today is 0.67.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shinva Medical Instrument Co was 2.76. The lowest was 0.60. And the median was 0.94.


Shinva Medical Instrument Co  (SHSE:600587) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shinva Medical Instrument Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.98/19.28
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Shinva Medical Instrument Co was 2.76. The lowest was 0.60. And the median was 0.94.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Shinva Medical Instrument Co Cyclically Adjusted Revenue per Share Related Terms


Shinva Medical Instrument Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Shinva Medical Instrument Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shinva Medical Instrument Co Cyclically Adjusted Revenue per Share Chart

Shinva Medical Instrument Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.70 17.90 18.71 19.12 19.24

Shinva Medical Instrument Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.18 19.16 19.19 19.24 19.28

SHSE:600587 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Shinva Medical Instrument Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shinva Medical Instrument Co Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shinva Medical Instrument Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shinva Medical Instrument Co's Cyclically Adjusted PS Ratio falls into.


SHSE:600587
65GF Score
Shinva Medical Instrument Co Ltd SHSE:600587
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shinva Medical Instrument Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shinva Medical Instrument Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.634/116.3033*116.3033
=3.634

Current CPI (Mar. 2026) = 116.3033.

Shinva Medical Instrument Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.594 101.400 4.122
201609 4.049 102.400 4.599
201612 5.960 102.600 6.756
201703 4.046 103.200 4.560
201706 4.619 103.100 5.211
201709 4.994 104.100 5.579
201712 5.660 104.500 6.299
201803 4.093 105.300 4.521
201806 4.682 104.900 5.191
201809 4.984 106.600 5.438
201812 7.631 106.500 8.333
201903 3.828 107.700 4.134
201906 4.088 107.700 4.415
201909 3.929 109.800 4.162
201912 4.677 111.200 4.892
202003 3.187 112.300 3.301
202006 4.552 110.400 4.795
202009 4.585 111.700 4.774
202012 5.220 111.500 5.445
202103 4.761 112.662 4.915
202106 5.571 111.769 5.797
202109 3.613 112.215 3.745
202112 4.007 113.108 4.120
202203 3.949 114.335 4.017
202206 4.307 114.558 4.373
202209 4.185 115.339 4.220
202212 5.021 115.116 5.073
202303 4.392 115.116 4.437
202306 7.856 114.558 7.976
202309 4.931 115.339 4.972
202312 4.492 114.781 4.552
202403 4.194 115.227 4.233
202406 7.082 114.781 7.176
202409 3.705 115.785 3.722
202412 3.075 114.893 3.113
202503 3.883 115.116 3.923
202506 4.063 114.907 4.112
202509 3.620 115.471 3.646
202512 4.519 115.832 4.537
202603 3.634 116.303 3.634

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥19.28 mean?
Shinva Medical Instrument Co (SHSE:600587) has a Cyclically Adjusted Revenue per Share of ¥19.28 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shinva Medical Instrument Co and its competitors.
Is Shinva Medical Instrument Co's Cyclically Adjusted Revenue per Share too high?
Shinva Medical Instrument Co's current Cyclically Adjusted Revenue per Share is ¥19.28. Overall, Shinva Medical Instrument Co has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shinva Medical Instrument Co's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Shinva Medical Instrument Co's Cyclically Adjusted Revenue per Share of ¥19.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Shinva Medical Instrument Co and its competitors. Shinva Medical Instrument Co's current Cyclically Adjusted Revenue per Share is ¥19.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shinva Medical Instrument Co stock overvalued right now?
Based on GuruFocus' analysis, Shinva Medical Instrument Co (SHSE:600587) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥15.64, compared to a current price of ¥12.98 — trading 17% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥19.28. Shinva Medical Instrument Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Shinva Medical Instrument Co (SHSE:600587), the current Cyclically Adjusted Revenue per Share is ¥19.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shinva Medical Instrument Co (SHSE:600587) Overvalued in 2026?

Based on GuruFocus' analysis, Shinva Medical Instrument Co stock appears to be undervalued. The current stock price of ¥12.98 is trading 17% below its estimated GF Value™ of ¥15.64. GuruFocus considers Shinva Medical Instrument Co to be Modestly Undervalued.

Key valuation signals for SHSE:600587:

  • Cyclically Adjusted Revenue per Share: ¥19.28
  • GF Value™: ¥15.64 vs. price of ¥12.98 (17% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600587 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shinva Medical Instrument Co Business Description

Address Xinhua Medical Technology Park, New and High-Technology Development Zone, Shandong, Zibo, CHN, 255086
Shinva Medical Instrument Co Ltd manufactures medical instruments in China. Its main products include sterilizers and testing products, radiotherapy and digital diagnosis equipment, surgical instruments and pharmaceutical machinery.
65GF Score

Get the complete analysis for SHSE:600587

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.98
Price
¥15.64
GF Value